CME Group (CME) analyst forecast and price target
Analyst forecast
Consensus of 19 analyst ratings
Based on 9 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Overweight | $315.00 from $301.00 | Oct 14, 2026 |
| Morgan Stanley | Maintained | Overweight | $337.00 from $330.00 | Oct 9, 2026 |
| Barclays | Maintained | Equal-Weight | $281.00 from $270.00 | Oct 7, 2026 |
| TD Cowen | Maintained | Buy | $300.00 from $292.00 | Oct 5, 2026 |
| UBS | Maintained | Neutral | $270.00 from $260.00 | Oct 5, 2026 |
| Wells Fargo | Initiated Coverage | Overweight | $301.00 | Oct 2, 2026 |
| TD Cowen | Maintained | Buy | $292.00 | Sep 28, 2026 |
| TD Cowen | Maintained | Buy | $292.00 | Sep 3, 2026 |
| Deutsche Bank | Downgraded | Buy → Hold | $270.00 from $286.00 | Aug 19, 2026 |
| Morgan Stanley | Maintained | Overweight | $330.00 from $324.00 | Jul 23, 2026 |
| B of A Securities | Maintained | Underperform | $230.00 from $226.00 | Jul 23, 2026 |
| JP Morgan | Maintained | Underweight | $250.00 from $249.00 | Jul 23, 2026 |
| Piper Sandler | Maintained | Overweight | $295.00 from $329.00 | Jul 15, 2026 |
| Morgan Stanley | Maintained | Overweight | $324.00 from $353.00 | Jul 10, 2026 |
| Barclays | Maintained | Equal-Weight | $270.00 from $316.00 | Jul 9, 2026 |
| UBS | Maintained | Neutral | $260.00 from $310.00 | Jul 6, 2026 |
| Raymond James | Maintained | Outperform | $320.00 | Jul 2, 2026 |
| Keefe, Bruyette & Woods | Upgraded | Market Perform → Outperform | $305.00 | Jun 18, 2026 |
| Rothschild & Co | Upgraded | Neutral → Buy | $323.00 from $316.00 | Jun 11, 2026 |
| Barclays | Maintained | Equal-Weight | $316.00 from $343.00 | Apr 23, 2026 |
Frequently asked questions
What is the price target for CME stock?
The average 12-month analyst price target for CME Group (CME) is $283.11, with a high estimate of $337.00 and a low of $230.00, across 9 analysts.
Is CME a buy, sell, or hold?
Analysts covering CME Group currently average a Buy rating: 10 buy, 6 hold and 3 sell, from 19 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for CME?
The average price target of $283.11 implies 0.87% downside from the last price of $285.59.
What is the latest analyst rating on CME?
On Oct 14, 2026, Wells Fargo maintained CME Group at Overweight with a price target of $315.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.